{"address1": "700 Brooker Creek Boulevard", "address2": "Suite 1800", "city": "Oldsmar", "state": "FL", "zip": "34677", "country": "United States", "phone": "813 749 2100", "fax": "813 855 4745", "website": "https://www.cryo-cell.com", "industry": "Medical Care Facilities", "industryDisp": "Medical Care Facilities", "sector": "Healthcare", "longBusinessSummary": "Cryo-Cell International, Inc. engages in the cellular processing and cryogenic cellular storage with a focus on the collection and preservation of umbilical cord blood stem cells for family use. It provides cord tissue service that stores a section of the umbilical cord tissue, a source of mesenchymal stem cells that are used in regenerative medicine to treat a range of conditions, including heart, and kidney disease, ALS, wound healing, and auto-immune diseases. The company also manufactures and sells PrepaCyte CB processing system, a technology used to process umbilical cord blood stem cells. It markets its cord blood stem cell preservation services directly to expectant parents, as well as by distributing information through obstetricians, pediatricians, childbirth educators, certified nurse-midwives, and other related healthcare professionals. The company was incorporated in 1989 and is headquartered in Oldsmar, Florida.", "fullTimeEmployees": 80, "companyOfficers": [{"maxAge": 1, "name": "Mr. David I. Portnoy", "age": 59, "title": "Chairman & Co-CEO", "yearBorn": 1963, "fiscalYear": 2022, "totalPay": 1070150, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark L. Portnoy", "age": 58, "title": "Co-CEO & Director", "yearBorn": 1964, "fiscalYear": 2022, "totalPay": 764000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jill M. Taymans", "age": 52, "title": "CFO & VP of Fin.", "yearBorn": 1970, "fiscalYear": 2022, "totalPay": 227985, "exercisedValue": 0, "unexercisedValue": 9525}, {"maxAge": 1, "name": "Mr. Oleg  Mikulinsky", "age": 49, "title": "Chief Information Officer", "yearBorn": 1973, "fiscalYear": 2022, "totalPay": 360000, "exercisedValue": 0, "unexercisedValue": 58100}, {"maxAge": 1, "name": "Dr. Joanne  Kurtzberg M.D.", "title": "Medical Director and Member of Medical & Scientific Advisory Board", "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 4.73, "open": 4.96, "dayLow": 4.72, "dayHigh": 4.92, "regularMarketPreviousClose": 4.73, "regularMarketOpen": 4.96, "regularMarketDayLow": 4.72, "regularMarketDayHigh": 4.92, "exDividendDate": 1661990400, "payoutRatio": 0.0, "beta": 0.314215, "trailingPE": 15.225805, "forwardPE": 31.466663, "volume": 4597, "regularMarketVolume": 4597, "averageVolume": 10211, "averageVolume10days": 11470, "averageDailyVolume10Day": 11470, "bid": 4.13, "ask": 5.42, "bidSize": 900, "askSize": 800, "marketCap": 39192992, "fiftyTwoWeekLow": 2.69, "fiftyTwoWeekHigh": 8.12, "priceToSalesTrailing12Months": 1.2682736, "fiftyDayAverage": 3.881, "twoHundredDayAverage": 4.7921, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "enterpriseValue": 48072540, "profitMargins": 0.08757, "floatShares": 4476971, "sharesOutstanding": 8303600, "sharesShort": 16515, "sharesShortPriorMonth": 11670, "sharesShortPreviousMonthDate": 1680220800, "dateShortInterest": 1682640000, "sharesPercentSharesOut": 0.002, "heldPercentInsiders": 0.47586, "heldPercentInstitutions": 0.12586, "shortRatio": 2.46, "shortPercentOfFloat": 0.003, "impliedSharesOutstanding": 0, "bookValue": -0.081, "lastFiscalYearEnd": 1669766400, "nextFiscalYearEnd": 1701302400, "mostRecentQuarter": 1677542400, "earningsQuarterlyGrowth": -0.078, "netIncomeToCommon": 2706173, "trailingEps": 0.31, "forwardEps": 0.15, "enterpriseToRevenue": 1.556, "enterpriseToEbitda": 7.885, "52WeekChange": -0.23586428, "SandP52WeekChange": 0.046755195, "lastDividendValue": 0.9, "lastDividendDate": 1661990400, "exchange": "ASE", "quoteType": "EQUITY", "symbol": "CCEL", "underlyingSymbol": "CCEL", "shortName": "Cryo-Cell International, Inc.", "longName": "Cryo-Cell International, Inc.", "firstTradeDateEpochUtc": 765466200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "a1560c8d-f04b-31e1-b948-8f4c97cf7f8b", "messageBoardId": "finmb_378115", "gmtOffSetMilliseconds": -14400000, "currentPrice": 4.72, "targetHighPrice": 10.0, "targetLowPrice": 10.0, "targetMeanPrice": 10.0, "targetMedianPrice": 10.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 2213376, "totalCashPerShare": 0.267, "ebitda": 6097002, "totalDebt": 11009869, "quickRatio": 0.462, "currentRatio": 0.562, "totalRevenue": 30902632, "revenuePerShare": 3.657, "returnOnAssets": 0.04779, "returnOnEquity": 1.5187199, "grossProfits": 21544391, "freeCashflow": -6808467, "operatingCashflow": 8709814, "earningsGrowth": -0.078, "revenueGrowth": 0.078, "grossMargins": 0.71664, "ebitdaMargins": 0.1973, "operatingMargins": 0.14964, "financialCurrency": "USD", "trailingPegRatio": null}